Journals / Klinik Psikiyatri Dergisi / 2003 / Cilt: 6 - Sayı: 3

An interferon-alfa induced psychotic disorder in a patient with chronic hepatitis C

İnterferon alfa kullanımına bağlı psikotik bozukluk: Olgu sunumu

Pages
170–173
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this paper we presented the case of induced IF-alpha psychotic symptomps in a women with chronic hepatitis C after the administration of standart dose of IF- alpha.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Interferon-alfa (IF-alpha) bacterially synthesized agent with antivi-ral, antiproliferative and immunomodulatory properties.
📊
Key Findings & Data:IF-a has been approved for the treatment of the several types of cancer (leukemia, lymphoma, renal cell carcinoma and melanoma) and of chronic hepatitis.Usually causing flu like symptoms, IF-a has more serious adverse effects related to the central nervous system, including a spectrum of psychiatric side effects, such as anxiety, depression, irritability, psychosis, delirium, mania, demantia and suicide.
💡
Conclusion & Impact:In this paper we presented the case of induced IF-alpha psychotic symptomps in a women with chronic hepatitis C after the administration of standart dose of IF- alpha.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Orta Yaş · Psikoz · maddeye bağlı

Abstract

Interferon-alfa (IF-alpha) bacterially synthesized agent with antivi-ral, antiproliferative and immunomodulatory properties. IF-a has been approved for the treatment of the several types of cancer (leukemia, lymphoma, renal cell carcinoma and melanoma) and of chronic hepatitis.Usually causing flu like symptoms, IF-a has more serious adverse effects related to the central nervous system, including a spectrum of psychiatric side effects, such as anxiety, depression, irritability, psychosis, delirium, mania, demantia and suicide. Adverse psychiatric side effects are related to dose. They are usually reversable, though sometimes may be persistant. In this paper we presented the case of induced IF-alpha psychotic symptomps in a women with chronic hepatitis C after the administration of standart dose of IF- alpha.

Özet

Interferon alfa (IF-alfa) antiviral, antiproliferatifve immünomodulatör özellikleri olan bakterilerden sentez edilen bir ilaçtır. İnterferon-alfa bazı kanser tiplerinde (lösemi, lenfoma, renal hücreli kanser ve melanoma gibi) ve kronik hepatit enfeksiyonlarının sağaltımında kullanılmaktadır. Sıklıkla flu-like sendroma neden olur. Anksiyete, depresyon, irritabilite, psikoz, deliryum, mani, demons gibi psikiyatrik yan etkileri de içine alan, santral sinir sistemini etkilemesine bağlı çok sayıda ciddi yan etkileri vardır. Psikiyatrik yan etkiler dozla ilişkilidir. Bu yan etkiler genellikle geri dönüşümlüdür, nadiren kalıcı olabilirler. Bu yazıda standart dozda Interferon alfa (IF-alfa) kullanan, kronik hepatit-Cli bir bayan hastada gelişen psikoz olgusunu sunduk.

🔖

Cite This Article

UĞUZ, Ş., YURDAGÜL, E., AYDIN, H., ÜNAL, M. (2003). An interferon-alfa induced psychotic disorder in a patient with chronic hepatitis C. Klinik Psikiyatri Dergisi, Cilt: 6 - Sayı: 3, 170–173. https://ajindex.com/articles/208937

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Blalock JE, Smith EM (1980) Human leukocyte interferon (IFNalpha) potent endorphin-like opioid activity. Proc Natl Acad SciUSA, 77:5972-5974.
  2. Dieperink E, Willenbring M, Ho BS (2000) Neuropsychiatricsymptoms associated with hepatitis C and interferon alpha:reiview. Am J Psychiatry, 157:867-876.
  3. Dusheiko G (1997) Side effects of alpha interferon in chronichepatitis C. Hepatology, 26(Suppl 1):112-121.
  4. Fattovich G, Giustina G, Favarato S ve ark. (1996) A survey ofadverse events in 11241 patients with chronic viral hepatitistreated with alfa interferon. J Hepatol, 24:38-47.
  5. Fried MW, Shiffman ML, Reddy KR ve ark. (2002)Peginterferon alfa-2a plus ribavirin for chronic hepatitis Cvirus infection. N Engl J Med, 347:975-982.
  6. Fried MV (2002) Side effects of therapy of hepatitis C and theirmanagement. Hepatology, 36(Suppl 1):237-244.
  7. Katila H, Cantell C, Appelberg B ve ark. (1993) Interferonalpha as adjuvant treatment in chronic schizophrenia.Neuropsychobiology, 28:192-196.
  8. Ledinghen V, Triomulet P, Winnock M ve ark. (2002) Daily orthree times a week interferon alfa in combination with rib-avirin or interferon alone for the treatment of patients withchronic hepatitis C. J Hepatol, 36:672-680.
  9. Lerner DM, Stoudemire A, Rosenstein DL (1999)Neuropsychiatric toxicity associated with cytokine therapies.Psychosomatics, 40:428-435.
  10. Manns MP, McHutchinson JG, Gordon SC ve ark. (2001)Peginterferon alfa-2b plus ribavirin compared with interferonalfa-2b plus ribavirin for initial treatment of chronic hepatitisC: A randomized trial. Lancet, 358:958-965.
  11. McHutchinson JG, Gordon SC, Schiff ER ve ark. (1998)Interferon alfa-2b alone or in combination with ribavirin asinitial treatment for chronic hepatitis C. N Engl J Med,339:1485-1492.
  12. Monji A, Yoshido I, Tashiro KI ve ark. (1998) A case of persis-tant manic depressive illness induced by interferon alpha inthe trestment hepatitis. Psycosomatics, 39:562-564.
  13. Okanoue T, Sakamoto S, Itoh Y ve ark. (1996) Side effects ofhigh-dose interferon therapy for chronic hepatitis C. JHepatology, 25:283-291.
  14. Renault PF, Hoofnagle JH, Park Y ve ark. (1987) Psychiatriccomplications of long term interferon alfa therapy. Arch InternMed, 147:1577-1580.
  15. Samuel B, Huy Nguyen MD, Lori L ve ark. (2001) Influence ofpsychiatric diagnoses on interferon-alpha treatment for chron-ic hepatitis C in a veteran population. Am J Gastroenterol,96:157-163.
  16. Saracco G, Rosina F, Abate ML ve ark. (1993) Long term fol-low-up of patients with chronic hepatitis C treated w